Authors:
COLEMAN M
MULLER S
QUEZADA A
MENDIRATTA SK
WANG JJ
THULL NM
BISHOP J
MATAR M
MESTER J
PERICLE F
Citation: M. Coleman et al., NONVIRAL INTERFERON-ALPHA GENE-THERAPY INHIBITS GROWTH OF ESTABLISHEDTUMORS BY ELICITING A SYSTEMIC IMMUNE-RESPONSE, Human gene therapy, 9(15), 1998, pp. 2223-2230
Authors:
BRONTE V
WANG M
OVERWIJK WW
SURMAN DR
PERICLE F
ROSENBERG SA
RESTIFO NP
Citation: V. Bronte et al., APOPTOTIC DEATH OF CD8(-LYMPHOCYTES AFTER IMMUNIZATION - INDUCTION OFA SUPPRESSIVE POPULATION OF MAC-1(+)() T)GR-1(+) CELLS/, The Journal of immunology (1950), 161(10), 1998, pp. 5313-5320
Authors:
PERICLE F
PINTO LA
HICKS S
KIRKEN RA
SCONOCCHIA G
RUSNAK J
DOLAN MJ
SHEARER GM
SEGAL DM
Citation: F. Pericle et al., CUTTING EDGE - HIV-1 INFECTION INDUCES A SELECTIVE REDUCTION IN STAT5PROTEIN EXPRESSION, The Journal of immunology, 160(1), 1998, pp. 28-31
Authors:
PERICLE F
EPLINGBURNETTE PK
PODACK ER
WEI S
DJEU JY
Citation: F. Pericle et al., CD40-CD40L INTERACTIONS PROVIDE 3RD-PARTY COSTIMULATION FOR T-CELL RESPONSE AGAINST B7-1-TRANSFECTED HUMAN BREAST-TUMOR CELLS, Journal of leukocyte biology, 61(2), 1997, pp. 201-208
Authors:
PERICLE F
KIRKEN RA
BRONTE V
SCONOCCHIA G
DASILVA L
SEGAL DM
Citation: F. Pericle et al., IMMUNOCOMPROMISED TUMOR-BEARING MICE SHOW A SELECTIVE LOSS OF STAT5A B EXPRESSION IN T-LYMPHOCYTES AND B-LYMPHOCYTES/, The Journal of immunology, 159(6), 1997, pp. 2580-2585
Citation: F. Pericle et al., HYALURONAN-BINDING TO CD44 ON HUMAN NEUTROPHILS INDUCES PMN TUMORICIDAL ACTIVITY, The FASEB journal, 10(6), 1996, pp. 2696-2696
Citation: F. Pericle et al., CD44 IS A CYTOTOXIC TRIGGERING MOLECULE ON HUMAN POLYMORPHONUCLEAR CELLS, The Journal of immunology, 157(10), 1996, pp. 4657-4663
Authors:
PERICLE F
KIRKEN RA
EPLINGBURNETTE PK
BLANCHARD DK
DJEU JY
Citation: F. Pericle et al., DIRECT KILLING OF INTERLEUKIN-2-TRANSFECTED TUMOR-CELLS BY HUMAN NEUTROPHILS, International journal of cancer, 66(3), 1996, pp. 367-373
Authors:
GAMERO AM
PERICLE F
EPLINGBURNETTE PK
LIU JH
WEI S
COX C
DJEU JY
Citation: Am. Gamero et al., INTERLEUKIN-15 (IL-15) PROVIDES AN ACCESSORY SIGNAL TO B7-1 COSTIMULATION FOR THE GENERATION OF CYTOLYTIC T-CELLS, Blood, 88(10), 1996, pp. 1242-1242
Authors:
EPLINGBURNETTE PK
WEI S
LIU JH
PERICLE F
USSERY DW
RUSSELL SM
LEONARD WJ
DJEU JY
Citation: Pk. Eplingburnette et al., EXPRESSION OF INTERLEUKIN-2 RECEPTOR-GAMMA ON HUMAN MONOCYTES - CHARACTERIZATION OF LINEAGE-SPECIFIC POSTTRANSLATIONAL MODIFICATIONS, European Journal of Immunology, 25(1), 1995, pp. 291-294
Authors:
WEI S
BLANCHARD DK
DUAN C
PERICLE F
DIAZ J
DJEU JY
Citation: S. Wei et al., ROLE OF EXTRACELLULAR ADENOSINE-TRIPHOSPHATE IN THE CYTOTOXIC T-LYMPHOCYTE-MEDIATED LYSIS OF ANTIGEN-PRESENTING CELLS, Blood, 86(10), 1995, pp. 6425-6425
Authors:
BLANCHARD DK
WEI S
DUAN CN
PERICLE F
DIAZ JI
DJEU JY
Citation: Dk. Blanchard et al., ROLE OF EXTRACELLULAR ADENOSINE-TRIPHOSPHATE IN THE CYTOTOXIC T-LYMPHOCYTE-MEDIATED LYSIS OF ANTIGEN-PRESENTING CELLS, Blood, 85(11), 1995, pp. 3173-3182
Authors:
MUSIANI P
MODESTI A
BRUNETTI M
MODICA A
VITULLO P
GULINO A
BOSCO MC
COLOMBO MP
NANNI P
CAVALLO F
PERICLE F
GIOVARELLI M
CAVALLO R
FORNI G
Citation: P. Musiani et al., NATURE AND POTENTIAL OF THE REACTIVE RESPONSE TO MOUSE MAMMARY ADENOCARCINOMA CELLS ENGINEERED WITH INTERLEUKIN-2, INTERLEUKIN-4 OR INTERFERON-GAMMA GENES, Natural immunity, 13(2-3), 1994, pp. 93-101
Authors:
PERICLE F
GIOVARELLI M
COLOMBO MP
FERRARI G
MUSIANI P
MODESTI A
CAVALLO F
DIPIERRO F
NOVELLI F
FORNI G
Citation: F. Pericle et al., AN EFFICIENT TH2-TYPE MEMORY FOLLOWS CD8(-DRIVEN AND EOSINOPHIL-MEDIATED REJECTION OF A SPONTANEOUS MOUSE MAMMARY ADENOCARCINOMA ENGINEEREDTO RELEASE IL-4() LYMPHOCYTE), The Journal of immunology, 153(12), 1994, pp. 5659-5673
Authors:
ROSSI AR
PERICLE F
RASHLEIGH S
JANIEC J
DJEU JY
Citation: Ar. Rossi et al., LYSIS OF NEUROBLASTOMA CELL-LINES BY HUMAN NATURAL-KILLER-CELLS ACTIVATED BY INTERLEUKIN-2 AND INTERLEUKIN-12, Blood, 83(5), 1994, pp. 1323-1328
Authors:
DIPIERRO F
CAVALLO F
PERICLE F
BERTINI S
GIOVARELLI M
FORNI G
Citation: F. Dipierro et al., STRATEGIES FOR CYTOKINE UTILIZATION IN TUMOR-THERAPY, Medical oncology and tumor pharmacotherapy, 10(1-2), 1993, pp. 53-59